PROBEN-C pharmaceutical API fine chemical vendors

Subscribe to access the full database, or Start Trial
Vendor	Vendor Homepage	Vendor Sku	API Url
Starshine Chemical	⤷ Start Trial	2023-05-13B00933	⤷ Start Trial
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: November 16, 2025

Introduction

Proben-C, a combination pharmaceutical formulation primarily comprising probenecid and cephalexin, is widely prescribed to treat bacterial infections and certain conditions associated with gout. The efficacy of Proben-C hinges on the quality and sourcing of its active pharmaceutical ingredients (APIs). Ensuring access to reliable, quality-controlled bulk APIs is essential for pharmaceutical companies, contract manufacturers, and quality assurance stakeholders to meet regulatory standards and to sustain supply chains amid market fluctuations.

Understanding PROBEN-C: Composition and API Roles

Proben-C combines two APIs:

Probenecid: A uricosuric agent used to treat gout by increasing uric acid excretion.
Cephalexin: A first-generation cephalosporin antibiotic effective against gram-positive bacteria.

For a consistent and high-quality production process, sourcing APIs from reputable suppliers with proven compliance to pharmacopeial standards (such as USP or EP) is vital.

API Sources for Probenecid

Market Overview

Probenecid has traditionally been manufactured by several multinational pharmaceutical companies. However, due to the niche nature of this API, the global market features a smaller pool of suppliers capable of complying with strict CGMP standards for API manufacturing.

Key Suppliers

Sandoz/Novartis: As a significant player in generic APIs, Sandoz supplies probenecid compliant with USP and other pharmacopoeias. Their manufacturing facilities are FDA-approved, and their APIs meet high purity standards [1].
Harrison Medical Research: Based in the US, this supplier provides high-quality probenecid bulk APIs with rigorous quality control measures suitable for regulatory approval.
Huvepharma: A European-based API manufacturer supplying probenecid with certification documents, collated with EU and US standards.

Emerging Suppliers

Zhejiang Hisun Pharmaceutical: Chinese API manufacturer with CE and GMP approvals, expanding global supply of probenecid.
Alkaloid AD: A reputable Bulgarian manufacturer with ISO certification capable of exporting GMP-compliant probenecid APIs.

Considerations for Procurement

Regulatory compliance: Confirm API suppliers meet USP, EP, or JP standards.
Quality assurance: Review batch records, stability data, and inspection reports.
Supply stability: Evaluate capacity and lead times to prevent shortages.

API Sources for Cephalexin

Global Suppliers and Manufacturing Hubs

Cephalexin has a broader manufacturing base, owing to its extensive use. Major pharmaceutical companies and API producers supply cephalexin globally.

Alphapharm (formerly Alphapharm Pty Ltd): An Australian manufacturer supplying GMP-grade cephalexin API.
Meiji Pharmaceutical: Japanese pharmaceutical company with a recognized API manufacturing facility producing cephalexin under strict regulatory oversight.
Aurobindo Pharma: Part of India’s leading API manufacturers, Aurobindo supplies cephalexin API compliant with major pharmacopeias.
China-based Producers: Several Chinese API manufacturers, such as Zhejiang NHU and Hubei Pharmaceutical, have expanded production of cephalexin API meeting GMP standards, offering cost-effective options with verified documentation.

Regional API Considerations

Asia (India, China): Cost-effective, large-volume suppliers; however, require diligent validation to ensure compliance with regulatory standards.
Europe/North America: Suppliers often have more extensive documentation and regulatory oversight, offering higher confidence levels.

Quality Factors

Registry of Certificates: GMP certificates, COAs, and stability reports.
Validation Data: Batch consistency, impurity profiles, residual solvents.
Supply Reliability: Multiple sourcing options due to high demand.

Sourcing Strategies and Validation

Risk Mitigation

To maintain a resilient supply chain, diversify API sources across regions and manufacturers. Establish robust qualifying and auditing procedures to verify supplier compliance.

Regulatory Alignment

Choose suppliers with registration and approvals compatible with target markets (FDA, EMA, PMDA). Ensure APIs have appropriate certificates such as DMFs (Drug Master Files) or Certificates of Suitability (CEP).

Cost-Efficiency and Supply Chain Optimization

Leverage competitive tenders in Asia for cost savings without compromising quality. Engage in long-term partnerships with established suppliers to foster stability.

Regulatory and Quality Assurance Considerations

Compliance with Pharmacopoeial Standards: Confirm APIs meet USP, EP, or JP monographs.
Documentation and Traceability: Ensure COAs, CoPs, and batch documentation are accessible and verifiable.
Supplier Qualification: Conduct on-site audits or third-party audits to validate manufacturing practices.

Emerging Trends and Market Dynamics

API Manufacturing Consolidation: Increasing OEM consolidation in Asia raises supply security but necessitates diligent validation.
Biotech and Synthetic Advances: Innovation in synthesis could impact the availability and cost of APIs such as probenecid and cephalexin.
Regulation and Quality Trends: Global tightening of manufacturing quality standards emphasizes the importance of API suppliers’ compliance with current CGMP norms.

Conclusion

Securing reliable bulk APIs for Proben-C demands comprehensive due diligence. Major global suppliers include established multinationals like Sandoz and Aurobindo for APIs such as probenecid and cephalexin. Emerging manufacturers, particularly in Asia, offer competitive alternatives but require thorough qualification. Implementing strategic sourcing, strict quality validation, and continuous supplier audits is essential to ensure high-quality API supply, regulatory compliance, and production continuity.

Key Takeaways

Due to niche market factors, sourcing probenecid API predominantly involves reputable European and US suppliers, with reliable Asian manufacturers as competitive alternatives.
Cephalexin APIs are widely available from Chinese, Indian, and Japanese producers, with Asia offering cost-effective options that require rigorous due diligence.
Aligning API sourcing strategies with regulatory requirements (GMP standards, documentation) minimizes risks of non-compliance.
Multi-sourcing and supplier qualification are vital for maintaining supply security and quality assurance.
Continuous market monitoring and supplier audits support adherence to evolving regulatory and quality standards.

FAQs

1. What factors should I consider when selecting an API supplier for Proben-C?
Focus on regulatory compliance (GMP, certificates), manufacturing capacity, quality assurance measures, supply stability, documentation transparency, and cost.

2. Are Chinese and Indian API manufacturers suitable for Proben-C production?
Yes, many Chinese and Indian suppliers produce high-quality, GMP-compliant APIs. Due diligence, including audits and validation, is essential to ensure quality.

3. How do I verify the quality of bulk APIs before procurement?
Request COAs, perform on-site supplier audits if possible, verify batch consistency, review stability and impurity profiles, and confirm certifications such as DMFs or CEPs.

4. Can I rely solely on Asian suppliers for both APIs?
While cost-effective, diversifying suppliers geographically mitigates risks related to geopolitical or supply chain disruptions. Combining Asian and Western suppliers enhances resilience.

5. What are upcoming trends in API sourcing for antibiotics like cephalexin?
Increased consolidation, enhanced manufacturing standards, and technological improvements in synthesis are key influences impacting API availability and quality.

References

[1] Sandoz Product Literature and GMP Certification Documentation.

Bulk Pharmaceutical API Sources for PROBEN-C